Anthony Manilla, DO
Otolaryngology · Hagerstown, MDNPI 1356332480
Payments from drug & device makers
What this record shows
Aerin Medical Inc. accounts for 70.1% of it on its own, with 12 other manufacturers making up the rest.
Across 51 payments — averaging $74.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$3K
- GSK$263
- Optinose US, Inc.$225
- Alk-abello, Inc$139
- Stryker$137
- AstraZeneca$84
- plus $295 from 7 others
What the payments were for
- Travel & lodging$1,63643%
- Food & beverage$2,18357%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 16 | $2,676 |
| GSK | 4 | $263 |
| Optinose US, Inc. | 12 | $225 |
| Alk-abello, Inc | 1 | $139 |
| Stryker | 6 | $137 |
| AstraZeneca | 1 | $84 |
| Intersect ENT, Inc. | 1 | $78 |
| Sanofi | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| Medtronic | 1 | $41 |
| Acclarent, Inc | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Novartis | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$1,833
- RHINAER STYLUS$1,288
- Odactra$139
- Vivaer RF Stylus$130
How this compares
$3,819 in reported general payments places this provider in the 80th percentile of 222 otolaryngology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 130 | $5,068 |
| Fluticasone Propionate | 249 | $5,030 |
| Ofloxacin | 68 | $1,920 |
| Mometasone Furoate | 15 | $1,285 |
| Azelastine Hcl | 14 | $560 |
| Pantoprazole Sodium | 21 | $503 |
| Montelukast Sodium | 30 | $416 |
| Omeprazole | 21 | $273 |
| Meclizine Hcl | 12 | $129 |
| Prednisone | 24 | $120 |
| Triamcinolone Acetonide | 24 | $94 |
| Doxycycline Hyclate | 13 | $69 |
| Amoxicillin | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Hagerstown
- Brian McKinnonHagerstown$5K
- Nathan DeckardHagerstown$3K
- Seth OringherChevy Chase$429K
- Marc DubinBaltimore$350K
- Douglas RehLutherville Timonium$231K
- Patrick HaBaltimore$41K
- Joshua LevyBethesda$40K
- Andrew LaneBaltimore$34K
- Jean KimBaltimore$29K
- Nicholas RowanBaltimore$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.